Summary:
A phase3 12 month, multicenter, open-label, flexibly-dose, safety-study of investigational medication in adults with Attention Deficit Hyperactivity Disorder (ADHD).
Qualified Participants Must:
• Feeling like you’re losing focus?
You could be experiencing symptoms of Attention Deficit Hyperactivity Disorder (ADHD).
Learn more about a medical research study evaluating an investigational medication for adults with ADHD.
Researchers are studying this investigational medication to gain more information about its safety and tolerability. If you qualify, you will take the investigational medication once daily for 12 months.
To pre-qualify for this study, you must be:
-Between 18-55 years of age
-Experiencing symptoms of ADHD or diagnosed with ADHD
All study-related visits, tests, and medication will be provided to participants at no cost. I addition, reimbursement for travel and related expenses may be provided.
To learn more, please contact: Medical & Behavioral Health Research, PC at P# 1888 317 6262.